Background
Pseudomonas aeruginosa (PA) is a major cause of morbidity and mortality among burn patients, despite antibiotic therapy. There is a need to identify innate immune defenses that prevent PA infection in injured adults in an effort to find therapeutic alternatives to antibiotics. Here, we tested our hypothesis that Microvesicles (MVs) in bronchoalveolar (BAL) fluid have a role in the immunity of the lung in response to pathogens.
Study Design
MVs were isolated from murine BAL fluid, quantified using nanoparticle tracking analysis, and injected into burn injured mice prior to PA infection. Survival was assessed and BAL bacterial loads enumerated. Neutrophil number and IL-6 activity were determined. Lungs were harvested and sphingosine (SPH) content analyzed via immunohistochemistry. Antimicrobial effects of MV and SPH enriched MVs were assessed in an in vitro assay.
Results
Burn injured mice have reduced BAL MV number and SPH content as compared to sham. When BAL MVs from healthy mice are administered to injured mice, survival and bacterial clearance are robustly improved. We further observed that intranasal administration of MVs restores SPH levels after burn injury, MVs directly kill bacteria, and this bacterial killing is increased when the MVs supplemented with SPH.
Conclusion
Using a pre-clinical model, BAL MVs are reduced after scald injury and BAL MV restoration to injured mice improves survival and bacterial clearance. The antimicrobial mechanisms leading to improved survival includes the quantity and SPH content of BAL MVs.